160 related articles for article (PubMed ID: 21652147)
1. Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma.
Shi HY; Lv FJ; Zhu ST; Wang QG; Zhang ST
Cancer Lett; 2011 Oct; 309(1):19-26. PubMed ID: 21652147
[TBL] [Abstract][Full Text] [Related]
2. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
[TBL] [Abstract][Full Text] [Related]
3. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.
Hoque A; Lippman SM; Wu TT; Xu Y; Liang ZD; Swisher S; Zhang H; Cao L; Ajani JA; Xu XC
Carcinogenesis; 2005 Apr; 26(4):785-91. PubMed ID: 15661803
[TBL] [Abstract][Full Text] [Related]
4. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
[TBL] [Abstract][Full Text] [Related]
5. Aspirin inhibits the proliferation of tobacco-related esophageal squamous carcinomas cell lines through cyclooxygenase 2 pathway.
Zhou QZ; Liu HB; Ding XC; Li P; Zhang ST; Yu ZL
Chin Med J (Engl); 2007 Dec; 120(23):2086-91. PubMed ID: 18167181
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells.
Hayashi T; Nishiyama K; Shirahama T
Int J Urol; 2006 Aug; 13(8):1086-91. PubMed ID: 16903934
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
Santander S; Cebrián C; Esquivias P; Conde B; Esteva F; Jiménez P; Ortego J; Lanas A; Piazuelo E
Int J Oncol; 2012 Feb; 40(2):527-34. PubMed ID: 21971589
[TBL] [Abstract][Full Text] [Related]
10. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation.
Yu L; Chen M; Li Z; Wen J; Fu J; Guo D; Jiang Y; Wu S; Cho CH; Liu S
Mol Pharmacol; 2011 Mar; 79(3):608-17. PubMed ID: 21177414
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
Nystrom ML; McCulloch D; Weinreb PH; Violette SM; Speight PM; Marshall JF; Hart IR; Thomas GJ
Cancer Res; 2006 Nov; 66(22):10833-42. PubMed ID: 17108119
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
14. Significance of COX-2 expression in human esophageal squamous cell carcinoma.
Zhi H; Wang L; Zhang J; Zhou C; Ding F; Luo A; Wu M; Zhan Q; Liu Z
Carcinogenesis; 2006 Jun; 27(6):1214-21. PubMed ID: 16352617
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of lipoxygenase inhibitors on murine bladder cancer cell line (MBT-2).
Ikemoto S; Sugimura K; Kuratukuri K; Nakatani T
Anticancer Res; 2004; 24(2B):733-6. PubMed ID: 15161019
[TBL] [Abstract][Full Text] [Related]
17. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways.
Agarwal S; Achari C; Praveen D; Roy KR; Reddy GV; Reddanna P
Exp Dermatol; 2009 Nov; 18(11):939-46. PubMed ID: 19558494
[TBL] [Abstract][Full Text] [Related]
19. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
[TBL] [Abstract][Full Text] [Related]
20. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
